Nemazoline

This classification denotes a histamine-1 receptor antagonist and alpha-adrenergic agonist, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier QUV3YCP28R. European Medicines Agency schedules Nemazoline in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB09190MIG. Nemazoline generally arises in the molecular formula C10H11CL2N3. The term NEMAZOLINE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 5, no. 3 1991, list 31.) NEMAZOLINE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule nemazoline under HS 29332990 and SITC 51573. As of Q4 2014, NEMAZOLINE remains the US FDA Preferred Term for this commodity. Nemazoline bears US NLM identifiers UMLS ID C2827281 and NCI Concept Code C83997. SMILES: C1CN=C(N1)CC2=CC(=C(C(=C2)CL)N)CL.